Free Trial

Nukkleus Inc. (NASDAQ:NUKK) CEO Acquires $771,084.32 in Stock

Nukkleus logo with Business Services background

Nukkleus Inc. (NASDAQ:NUKK - Get Free Report) CEO Anastasiia Kotaieva purchased 319,952 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $2.41 per share, with a total value of $771,084.32. Following the completion of the acquisition, the chief executive officer now directly owns 319,952 shares in the company, valued at approximately $771,084.32. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Nukkleus Price Performance

Shares of NUKK stock traded down $12.09 during trading hours on Friday, hitting $40.01. 3,934,354 shares of the company's stock were exchanged, compared to its average volume of 1,232,274. Nukkleus Inc. has a 52 week low of $1.30 and a 52 week high of $78.32. The stock's 50-day moving average is $4.98 and its 200-day moving average is $3.74.

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.

See Also

→ 3 CENT Crypto to Explode December 16th? (From True Market Insiders) (Ad)

Should you invest $1,000 in Nukkleus right now?

Before you consider Nukkleus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nukkleus wasn't on the list.

While Nukkleus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

3 Stocks That Wall Street Insiders Can't Stop Buying

3 Stocks That Wall Street Insiders Can't Stop Buying

Corporate insiders are snapping up shares of these three stocks heading into the new year; why this list of companies with insider buying might surprise you.

Recent Videos

This Investment Strategy Has the Highest Payout Potential
Watch These 4 Growth Sectors Thrive in 2025
3 Stocks That Wall Street Insiders Can’t Stop Buying

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines